Neurocrine Biosciences | NBIX

Aktienkurs
142.44
Täglich Wechseln
1.19 0.84%
Monatlich
-9.02%
Jährlich
4.25%
Q4 Prognose
140.07

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-11-03 FY2026Q3 PM 2.05 2.17
2026-07-30 FY2026Q2 PM 2.85 1.58 1.65
2026-05-05 FY2026Q1 PM 1.94 1.15 0.70
2026-02-11 FY2025Q4 PM 1.88 1.86 1.69
2025-10-28 FY2025Q3 PM 2.17 1.56 1.81



Preis Chg Tag Jahr Datum
AbbVie 276.47 4.05 1.49% 19.94% 2026-10-09
Acadia Pharmaceuticals 19.78 0.20 1.02% -1.40% 2026-10-09
Agios Pharmaceuticals 31.81 -0.11 -0.34% -21.67% 2026-10-09
ALKERMES 40.61 0.50 1.25% 30.12% 2026-10-09
Alnylam Pharmaceuticals 232.68 8.15 3.63% -49.47% 2026-10-09
Amgen 414.87 7.43 1.82% 42.99% 2026-10-09
Biogen 225.71 7.28 3.33% 53.99% 2026-10-09
BioMarin Pharmaceutical 54.80 -0.09 -0.16% 4.74% 2026-10-09
Cytokinetics 62.91 0.90 1.45% 4.78% 2026-10-09
Enanta Pharmaceuticals 12.50 0.40 3.31% 13.43% 2026-10-09

Preis Tag Jahr Datum
USND 27366 172.83 0.64% 23.25% 2026-10-09
US2000 2807 12.85 0.46% 17.22% 2026-10-09